SM04690 for Osteoarthritis: Emerging Drug Insight and Market Forecasts to 2032 - Focus on 6 Major Markets
January 24, 2024 08:59 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "SM04690 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This "SM04690 Emerging Drug...
Healthcare Industry Report: DB102 Emerging Drug Insights and Market Forecast for DLBCL through 2032
January 24, 2024 07:47 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "DB102 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. A newly compiled research report...
Small Molecule Drug Discovery Global Market Report 2024: Patient-Centric Approaches and Artificial Intelligence Transforms Drug Discovery in Small Molecule Research - Forecasts to 2028 and 2033
January 24, 2024 07:36 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Small Molecule Drug Discovery Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The small molecule drug discovery...
Small Molecule Immunomodulators Market Size will Expand to USD 270.77 Billion to 2031 | Reveals InsightAce Study
January 24, 2024 00:11 ET
|
InsightAce Analytic Pvt. LTd.
Jersey City, NJ, Jan. 24, 2024 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Small Molecule Immunomodulators Market - (By...
Small Molecule CMO/CDMO Market Worth to Surpass US$ 102.01 Billion by 2030 - Insights by Persistence Market Research
January 23, 2024 07:39 ET
|
Persistence Market Research
New York, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The global small molecule CMO/CDMO market is anticipated to grow at a 5.1% CAGR, reaching US$102.01 billion by 2030 from its 2023 value of US$72.01...
2 Day Analytical Methods Validation for FDA Compliance Drugs and Biologics Course 2024: Pre-Approved by RAPS as Eligible for Up to 9 Credits Towards RAC Recertification
January 18, 2024 07:08 ET
|
Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Analytical Methods Validation for FDA Compliance Drugs and Biologics" training has been added to ResearchAndMarkets.com's offering. This Analytical...
Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry
December 20, 2023 07:59 ET
|
Recursion Pharmaceuticals
KYIV, Ukraine and SALT LAKE CITY, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today...
Global Biologics Drug Discovery Market Analysis, 2023-2033: Dominated by AbbVie, Amgen, AstraZeneca, and Pfizer
December 19, 2023 12:08 ET
|
Research and Markets
Dublin, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The "Biologics Drug Discovery Market - A Global and Regional Analysis, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The dynamic...
Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodium for Use as Anticancer and Antiviral Vaccine Adjuvant
December 18, 2023 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (USPTO) has allowed patent application 17/488,430, titled...
TCR-Therapy Pipeline Research Report 2023: Comprehensive Insights on 30+ Companies and 100+ Pipeline Drugs
November 22, 2023 08:48 ET
|
Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "TCR-Therapy - Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...